See also this year's filing and all EDGAR filings for this company.
PDF Report 0001799191_2021_Oncology_Institute_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.2589042568439157, 'aggregate_val': 248190000, 'exp_sum': 334896000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 83365000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 248861000, 'DepreciationDepletionAndAmortization': 3341000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': -671000}} |
Graph
Absolute values for 0001799191, Oncology Institute Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 0 |
| 2 | AssetsCurrent | 1,069,461 |
| 3 | PropertyPlantAndEquipment | 0 |
| 4 | remainder_Assets | 230,254,149 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 267,550 |
| 7 | remainder_Liabilities | 25,091,170 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 0 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | 11,434 |
| 17 | remainder_Revenues | 0 |
| 18 | remainder_NetIncome | -8,328,470 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 231,323,610 |
| 1 | Liabilities | 25,358,720 |
| 2 | Expenses | 11,434 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 205,964,890 |
| 5 | NetIncome | -8,339,904 |
| 6 | ComprehensiveNetIncome | -8,339,904 |
| 7 | BaseVar | 132,511,117 |
| 8 | EconomicCapitalRatio | 4.40 |
Edgar->Model Mapping
Feature Distribution
